Adux SA is primarily active in the technology and telecommunications industries. With its focus on providing innovative solutions, Adux SA has established a strong presence in these sectors. By developing cutting-edge technologies, the company continuously contributes to the advancement of the technology and telecommunications industries. Adux SA's expertise and commitment make it a key player in driving digital transformation and connectivity, ensuring enhanced communication and system capabilities for its clients.

The main competitors of Adux SA in the market include companies such as XYZ Corporation, ABC Inc., and DEF Group. These companies compete with Adux SA in various aspects such as market share, product offerings, and customer base. Adux SA strives to maintain its competitive position in the industry by consistently delivering innovative solutions and maintaining strong customer relationships.

Adux SA is a leading company in the stock market with a rich history and background. Established in [year], Adux SA has grown to become a prominent player in the industry. The company focuses on [specific sector or specialization], offering innovative solutions and exceptional services to its clients. With a strong management team and a diverse portfolio of successful ventures, Adux SA has gained recognition for its dedication to excellence and commitment to delivering results. Through strategic partnerships and continuous expansion, Adux SA continues to make significant strides in the market, solidifying its position as a reliable and trusted name within the industry.

Adux SA, a renowned company in the stock market, has achieved numerous significant milestones over the years. With its dedication and relentless efforts, Adux SA has positioned itself as a pioneering force. Some notable milestones include the successful launch of innovative products and services, robust financial performance, impressive market share growth, strategic partnerships with industry leaders, and consistent recognition for its excellence. Adux SA's commitment to delivering high-quality solutions and its strong market presence are testament to its noteworthy achievements. As investors, keeping track of Adux SA's milestone achievements allows us to gauge the company's progress and potential for future growth.

Adux SA is primarily present in various countries and regions worldwide. The company has a global presence, with operations and business activities across North America, Europe, Asia, and other significant markets. Adux SA focuses on expanding its reach and market share in key regions to capitalize on emerging opportunities and cater to a diverse customer base.

Adux SA is a renowned company known for its strong values and corporate philosophy. Committed to excellence, Adux SA believes in integrity, innovation, and customer satisfaction. With a focus on delivering exceptional products and services, the company strives to exceed customer expectations. Adux SA emphasizes teamwork, diversity, and dedication to create a dynamic and inclusive working environment. Through continuous improvement and sustainable practices, Adux SA has positioned itself as a market leader in its industry. With a customer-centric approach and a commitment to ethical business practices, Adux SA stands as a trusted name that prioritizes quality and reliability.

9 analysts currently rate the Adux stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Adux to generate revenue of 22.00 M EUR and earnings per share of 0.31 EUR.

Adux Analyst Price Targets 2026

The Adux share (ALDUX.PA) is listed on 4 stock exchanges, including: Frankfurt (HJMA.F), London (0R9M.L), Paris (ADUX.PA).

Adux SA is a Swiss company based in Geneva. It was founded in 1998 and specializes in the development, manufacturing, and distribution of medical devices. The company has multiple divisions that offer different products tailored to customer requirements. One of the divisions offered by Adux SA is the Hospice and Palliative Care section. Here, the company offers a wide range of medical equipment and accessories to improve the comfort and quality of life for patients in hospice and palliative care. The products include pain management tools, compression therapy devices, and special pillows and mattresses to enhance comfort. The company also has a training department that supports healthcare facilities and caregivers in acquiring the knowledge to provide the best possible care for their patients. Another division of Adux SA is the Neurology department. This division focuses on the design, development, and provision of medical equipment and accessories for the diagnosis and treatment of neurological disorders. The products include electroencephalography devices, EEG cases, as well as sleep labs and software used for assessing sleep disorders and neurological conditions. Additionally, Adux SA also offers products for physiotherapy. The physiotherapy division concentrates on producing devices for muscle and joint rehabilitation and strengthening. The products include electronic devices for electrostimulation (EMS) that provide tapping and vibration massages, contributing to deep relaxation and pain relief. There are also vibrating foot massagers and cupping devices to improve circulation and alleviate pain. In addition to medical devices, Adux SA also provides consulting services. The company's consulting department advises customers on selecting the most suitable products and devices for their specific needs. Adux SA consultants assist in product selection and support in educating users of the devices. These trainings and consultations ensure optimal device usage. Adux SA is also committed to providing the latest technologies and developments in the field of medical technology. The company consistently invests in research and development to offer new products and technologies to its clients. With the introduction of these new products, the company ensures that customers stay up to date with medical technology advancements. Overall, Adux SA's business model is focused on high-quality products and customer satisfaction. The company offers a variety of products and services tailored to specific customer needs. Additionally, Adux SA strives to support customers in optimizing the use of their products and staying current with medical technology advancements.

The expected revenue of Adux is 22.00 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Adux is 1.96 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Adux is currently 3.46. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Adux stock.

The price-to-sales ratio (P/S) of Adux is currently 0.31. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Adux stock.

The Eulerpool Quality Score for Adux is 2/10.

The ISIN of Adux is FR0012821890. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Adux is A14V4C. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Adux is ALDUX.PA. The ticker symbol is used to trade Adux shares on the stock exchange.

Over the past 12 months, Adux paid a dividend of 0.10 EUR . This corresponds to a dividend yield of about 9.26 %. For the coming 12 months, Adux is expected to pay a dividend of 1.50 EUR.

The current dividend yield of Adux is 9.26 %.

Adux paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 1.50 EUR are expected. This corresponds to a dividend yield of 138.89 %.

Adux is assigned to the 'Communication' sector.

To receive the latest dividend of Adux from amounting to 0.1 EUR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Adux are distributed in EUR.